Darbepoetin alfa administered once every three weeks for the treatment of anemia in elderly patients with non-myeloid tumors receiving chemotherapy

MLA

Gaspar, Esquerdo, et al. “Darbepoetin Alfa Administered Once Every Three Weeks for the Treatment of Anemia in Elderly Patients with Non-Myeloid Tumors Receiving Chemotherapy.” Tumori, vol. 100, no. 2, May 2014. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........378b8ce50d6474eaeed7650f22a3333a&authtype=sso&custid=ns315887.

APA

Gaspar, E., Mercedes, D., Pilar, L., Carme, P., Kenny, V., Manuel, C., Pedro, S.-R., José A, G., César A, R., & Pilar, V. L. (2014). Darbepoetin alfa administered once every three weeks for the treatment of anemia in elderly patients with non-myeloid tumors receiving chemotherapy. Tumori, 100(2).

Chicago

Gaspar, Esquerdo, Doménech Mercedes, López Pilar, Pedro Carme, Villadiego Kenny, Constenla Manuel, Sánchez-Rovira Pedro, Gasquet José A, Rodríguez César A, and Vicente Lazcano Pilar. 2014. “Darbepoetin Alfa Administered Once Every Three Weeks for the Treatment of Anemia in Elderly Patients with Non-Myeloid Tumors Receiving Chemotherapy.” Tumori 100 (2). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........378b8ce50d6474eaeed7650f22a3333a&authtype=sso&custid=ns315887.